High Point Advisor Group LLC Bristol Myers Squibb CO Transaction History
High Point Advisor Group LLC
- $1.76 Billion
- Q2 2024
A detailed history of High Point Advisor Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, High Point Advisor Group LLC holds 59,523 shares of BMY stock, worth $3.08 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
59,523
Previous 52,175
14.08%
Holding current value
$3.08 Million
Previous $2.83 Million
12.65%
% of portfolio
0.14%
Previous 0.2%
Shares
22 transactions
Others Institutions Holding BMY
# of Institutions
2,402Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.66 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.21 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.73 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.86 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.06 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $110B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...